Daily vs. monthly oral vitamin D 3 for treatment of symptomatic vitamin D deficiency in infants: a randomized controlled trial
Journal of Pediatric Endocrinology and Metabolism · 26.07.2023 · 36 (7) · 683-691
DOI: 10.1515/jpem-2023-0146 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 18.05.2023. Verfasst von Anupriya Gora und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lady Hardinge Medical College, New Delhi, India. Hauptthemen laut MEDLINE: Cholecalciferol, Vitamin D Deficiency. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Objectives
Compare the efficacy and safety of daily vs. monthly oral vitamin D 3 in treating symptomatic vitamin D deficiency in infants.
Methods
90 infants with symptomatic vitamin D deficiency were randomized into Daily (D) [46 infants] and Bolus (B) [44 infants] groups to receive oral vitamin D 3 , daily (2000 IU/day) and bolus (60,000 IU/month) for three months respectively. Both groups received daily oral calcium @50 mg/kg/day. Serum calcium (Ca), phosphate (P), alkaline phosphatase (ALP), 25-hydroxy cholecalciferol [25(OH)D], parathyroid hormone (PTH) levels, urine calcium: creatinine ratio and radiological score were assessed at baseline, 4 and 12 weeks. At the end of 12 weeks, 78 infants were available for evaluation of efficacy and safety of both regimens.
Results
Both regimens led to a statistically significant increase in Ca and P levels and fall in ALP and PTH levels from baseline to 4 and 12 weeks of therapy, with no inter-group difference. Infants in group D had statistically significant higher mean 25(OH)D levels as compared to group B at 4 weeks (group D 130.89 ± 43.43 nmol/L, group B – 108.25 ± 32.40 nmol/L; p – 0.012) and 12 weeks (group D – 193.69 ± 32.47 nmol/L, group B – 153.85 ± 33.60 nmol/L; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lady Hardinge Medical College, New Delhi, India.
- Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India.
- Department of Biochemistry, Lady Hardinge Medical College, New Delhi, India.
- Department of Delhi Cancer Registry, BR Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Anju Seth
Zitieren
APA
Gora, A., Singh, P., Debnath, E., Malhotra, R. K., & Seth, A. (2023). Daily vs. monthly oral vitamin D 3 for treatment of symptomatic vitamin D deficiency in infants: a randomized controlled trial. Journal of Pediatric Endocrinology and Metabolism, 36(7), 683-691. https://doi.org/10.1515/jpem-2023-0146
Vancouver
Gora A, Singh P, Debnath E, Malhotra RK, Seth A. Daily vs. monthly oral vitamin D 3 for treatment of symptomatic vitamin D deficiency in infants: a randomized controlled trial. Journal of Pediatric Endocrinology and Metabolism. 2023;36(7):683-691. doi:10.1515/jpem-2023-0146
BibTeX
@article{Gora2023,
author = {Gora, Anupriya and Singh, Preeti and Debnath, Ekta and Malhotra, Rajeev Kumar and Seth, Anju},
title = {Daily vs. monthly oral vitamin D 3 for treatment of symptomatic vitamin D deficiency in infants: a randomized controlled trial},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2023},
volume = {36},
number = {7},
pages = {683--691},
doi = {10.1515/jpem-2023-0146}
}
EUVIMED